rs200877558

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_001004695.2(OR2T33):​c.479T>C​(p.Val160Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 17 hom., cov: 33)
Exomes 𝑓: 0.24 ( 66 hom. )
Failed GnomAD Quality Control

Consequence

OR2T33
NM_001004695.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.73

Publications

12 publications found
Variant links:
Genes affected
OR2T33 (HGNC:31255): (olfactory receptor family 2 subfamily T member 33) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024973452).
BP6
Variant 1-248273336-A-G is Benign according to our data. Variant chr1-248273336-A-G is described in ClinVar as Benign. ClinVar VariationId is 403272.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OR2T33NM_001004695.2 linkc.479T>C p.Val160Ala missense_variant Exon 2 of 2 ENST00000641220.1 NP_001004695.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OR2T33ENST00000641220.1 linkc.479T>C p.Val160Ala missense_variant Exon 2 of 2 NM_001004695.2 ENSP00000493437.1
OR2T33ENST00000318021.4 linkc.479T>C p.Val160Ala missense_variant Exon 1 of 1 6 ENSP00000324687.2

Frequencies

GnomAD3 genomes
AF:
0.0386
AC:
4268
AN:
110592
Hom.:
16
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0554
Gnomad AMI
AF:
0.0111
Gnomad AMR
AF:
0.0322
Gnomad ASJ
AF:
0.0261
Gnomad EAS
AF:
0.00915
Gnomad SAS
AF:
0.0245
Gnomad FIN
AF:
0.0413
Gnomad MID
AF:
0.0340
Gnomad NFE
AF:
0.0331
Gnomad OTH
AF:
0.0414
GnomAD2 exomes
AF:
0.281
AC:
46947
AN:
166848
AF XY:
0.289
show subpopulations
Gnomad AFR exome
AF:
0.191
Gnomad AMR exome
AF:
0.269
Gnomad ASJ exome
AF:
0.336
Gnomad EAS exome
AF:
0.118
Gnomad FIN exome
AF:
0.395
Gnomad NFE exome
AF:
0.327
Gnomad OTH exome
AF:
0.259
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.244
AC:
211383
AN:
865754
Hom.:
66
Cov.:
121
AF XY:
0.235
AC XY:
101799
AN XY:
432548
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.166
AC:
3715
AN:
22352
American (AMR)
AF:
0.168
AC:
4488
AN:
26732
Ashkenazi Jewish (ASJ)
AF:
0.133
AC:
2106
AN:
15804
East Asian (EAS)
AF:
0.0289
AC:
932
AN:
32208
South Asian (SAS)
AF:
0.0849
AC:
5009
AN:
59032
European-Finnish (FIN)
AF:
0.159
AC:
5111
AN:
32216
Middle Eastern (MID)
AF:
0.155
AC:
394
AN:
2548
European-Non Finnish (NFE)
AF:
0.286
AC:
182615
AN:
637828
Other (OTH)
AF:
0.189
AC:
7013
AN:
37034
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.274
Heterozygous variant carriers
0
20555
41110
61665
82220
102775
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8888
17776
26664
35552
44440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0387
AC:
4279
AN:
110664
Hom.:
17
Cov.:
33
AF XY:
0.0408
AC XY:
2202
AN XY:
53960
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0555
AC:
1782
AN:
32114
American (AMR)
AF:
0.0322
AC:
360
AN:
11166
Ashkenazi Jewish (ASJ)
AF:
0.0261
AC:
63
AN:
2410
East Asian (EAS)
AF:
0.00919
AC:
39
AN:
4244
South Asian (SAS)
AF:
0.0248
AC:
95
AN:
3824
European-Finnish (FIN)
AF:
0.0413
AC:
295
AN:
7150
Middle Eastern (MID)
AF:
0.0368
AC:
7
AN:
190
European-Non Finnish (NFE)
AF:
0.0331
AC:
1570
AN:
47384
Other (OTH)
AF:
0.0410
AC:
60
AN:
1464
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.303
Heterozygous variant carriers
0
442
884
1325
1767
2209
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.180
Hom.:
2
ExAC
AF:
0.388
AC:
47132

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.35
DANN
Benign
0.22
DEOGEN2
Benign
0.0066
T;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0087
N
LIST_S2
Benign
0.0016
.;T
MetaRNN
Benign
0.0025
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.33
N;N
PhyloP100
-1.7
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.020
.;N
REVEL
Benign
0.017
Sift
Benign
1.0
.;T
Sift4G
Benign
0.48
.;T
Polyphen
0.0
B;B
Vest4
0.056
MPC
1.3
ClinPred
0.0030
T
GERP RS
-2.8
PromoterAI
-0.00030
Neutral
Varity_R
0.037
gMVP
0.13
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200877558; hg19: chr1-248436638; COSMIC: COSV58813722; API